Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Columbia researchers identify 18 new genes that drive glioblastoma multiforme

Columbia researchers identify 18 new genes that drive glioblastoma multiforme

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

Specific mutations in FLT3 receptor can contribute to acute myeloid leukemia

Specific mutations in FLT3 receptor can contribute to acute myeloid leukemia

ImmunoGen reports net loss of $21.9 million in Q4 2013

ImmunoGen reports net loss of $21.9 million in Q4 2013

Study offers new hope for treatment of diffuse large B-cell lymphoma

Study offers new hope for treatment of diffuse large B-cell lymphoma

Researchers reveal location of human blood stem cells that may improve bone marrow transplants

Researchers reveal location of human blood stem cells that may improve bone marrow transplants

Finding could influence effectiveness of bone marrow transplants for late-stage leukemia

Finding could influence effectiveness of bone marrow transplants for late-stage leukemia

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

CHOP researchers advance stem cell studies in childhood leukemia, Diamond Blackfan anemia

CHOP researchers advance stem cell studies in childhood leukemia, Diamond Blackfan anemia

Technique for developing more targeted drugs using molecular "robots"

Technique for developing more targeted drugs using molecular "robots"

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Female cancer patients unhappy with the way doctors discussed about fertility preservation options

Female cancer patients unhappy with the way doctors discussed about fertility preservation options

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

Study shows CMEs can predict risk of cancer in type 2 diabetes patients

Study shows CMEs can predict risk of cancer in type 2 diabetes patients

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Largest data set of cancer-specific genetic variations generated by NCI scientists

Largest data set of cancer-specific genetic variations generated by NCI scientists

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.